Latest filing published 29 Jan 2026 for Sarepta Therapeutics, Inc., €120k.
Filing timeline
BuySaleInsider track record
Claude Nicaise: trading record in brief
This profile gathers the share dealings of Claude Nicaise in Sarepta Therapeutics, Inc., where the filings describe the role as senior executive. We count 13 filings; the first trade dates from 29 February 2016 and the latest from 29 January 2026.
Every open-market trade on record is a sale: 1 sale worth €227k. Besides market trades, the filings include 10 share grants and 2 option exercises.
On 29 January 2026 came the latest disclosure, an option exercise for €120k in Sarepta Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Claude Nicaise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,500 shares@ US$13.7134.8% of flowCommon StockSEC:0001193125-26-029895:0
- 2,491 shares@ US$99.64Common StockSEC:0000950170-25-039037:1
- 9,746 shares@ US$25.1865.2% of flowCommon StockSEC:0000950170-25-039037:0
- 2,383 sharesCommon StockSEC:0000950170-25-037522:0
- 1,846 shares0Common StockSEC:0000950170-24-026617:0
- 1,523 shares0Common StockSEC:0001209191-23-017405:0
- 2,953 shares0Common StockSEC:0001209191-22-017353:0
- 2,726 shares0Common StockSEC:0001209191-21-018419:0
- 2,075 shares0Common StockSEC:0001209191-20-014235:0
- 1,633 shares0Common StockSEC:0001209191-19-016034:0
- 3,418 shares0Common StockSEC:0001209191-18-017793:0
- 1,000 shares0Common StockSEC:0001209191-17-020686:0
- 1,000 shares0Common StockSEC:0001209191-16-104919:0
13 of 13 declarations
